Goodman Noah

EDGAR CIK 0002060075

Kymera Therapeutics, Inc. - KYMR

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Officer
Chief Business Officer
Direct Buys
0
$0
0 Shares
Direct Sells
2
($508,559)
-4,736 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
07/01/2026
10b5-1
07/02/2026
Sell
-3,389 @ $114.29
 ($387,329) 47,179 (-6.70%) Direct
04/14/2026
10b5-1
04/16/2026
Sell
-1,347 @ $90.00
 ($121,230) 50,195 (-2.61%) Direct